Compound 18
Identifiers
- Canonical SMILES:
OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cccnc1Cl
- IUPAC name:
(2S)-2-[(2-chloropyridine-3-carbonyl)amino]-3-(1H-indol-3-yl)propanoic acid
- InChi:
InChI=1S/C17H14ClN3O3/c18-15-12(5-3-7-19-15)16(22)21-14(17(23)24)8-10-9-20-13-6-2-1-4-11(10)13/h1-7,9,14,20H,8H2,(H,21,22)(H,23,24)/t14-/m0/s1
- InChiKey:
MPDJJMAOGCKNGY-AWEZNQCLSA-N
External links
44305116 |
CHEMBL66645 |
23156002 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 5.92 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 343.07 g/mol | |||
HBA | 6 | |||
HBD | 3 | |||
HBA + HBD | 9 | |||
AlogP | 2.46 | |||
TPSA | 95.08 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6492 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.6376 | Golotimod | DB05475 | |
0.6338 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
0.6333 | Rebamipide | DB11656 | |
0.6169 | Oglufanide | DB05779 | |
0.6165 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.6061 | Talmapimod | DB05412 | |
0.5970 | Nicofetamide | DB13531 | |
0.5890 | (2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid | DB03605 | |
0.5871 | Gramicidin D | DB00027 | |
0.5802 | D-Tryptophan | DB03225 | |
0.5802 | Tryptophan | DB00150 | |
0.5693 | Beta-Hydroxytryptophane | DB04159 | |
0.5688 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
0.5652 | Oxitriptan | DB02959 |